Literature DB >> 17206958

The epidemiology of preterm labour--why have advances not equated to reduced incidence?

P J Steer1.   

Abstract

The major burden of preterm birth is in the developing world, where most of the increasing death and morbidity is secondary to infectious diseases such as malaria, HIV, tuberculosis, bacterial vaginosis and intestinal parasites. In some developing countries, the growth of medical care has outstripped the growth of preventive public health, with an associated increase in iatrogenic preterm births. In developed countries, more than one-third of preterm births are medically indicated because of conditions such as fulminating pre-eclampsia or severe intrauterine growth restriction. Neither of these conditions is currently preventable. One in five preterm births is associated with multiple pregnancy, and these have been greatly increased by assisted reproduction techniques. The use of tocolytics has proved disappointing perhaps because inflammation rather than spontaneous uterine activity is increasingly recognised as the final common pathway. Inappropriate antibiotics used late in pregnancy are ineffective and may have adverse effects. Currently, the most promising interventions are public health related and include reducing the transmission of communicable diseases, improvements in the management of diabetes and reduction in harmful behaviours such as smoking and drug abuse.

Entities:  

Mesh:

Year:  2006        PMID: 17206958     DOI: 10.1111/j.1471-0528.2006.01116.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  13 in total

1.  Improving outcomes in pregnancy.

Authors:  John P Newnham
Journal:  BMJ       Date:  2007-04-21

Review 2.  Preterm birth prevention: how well are we really doing? A review of the latest literature.

Authors:  Sarit Avraham; Fouad Azem; Daniel Seidman
Journal:  J Obstet Gynaecol India       Date:  2014-06-07

3.  Immunologic Factors in Human Milk and Disease Prevention in the Preterm Infant.

Authors:  Katherine E Gregory; W Allan Walker
Journal:  Curr Pediatr Rep       Date:  2013-12

Review 4.  Genetic and epigenetic influences associated with intrauterine growth restriction due to in utero tobacco exposure.

Authors:  Melissa Suter; Adi Abramovici; Kjersti Aagaard-Tillery
Journal:  Pediatr Endocrinol Rev       Date:  2010-12

Review 5.  Prediction and prevention of preterm birth in pregnant women living with HIV on antiretroviral therapy.

Authors:  Amanda J Jones; Uzoamaka A Eke; Ahizechukwu C Eke
Journal:  Expert Rev Anti Infect Ther       Date:  2022-03-01       Impact factor: 5.854

Review 6.  Using proteomics in perinatal and neonatal sepsis: hopes and challenges for the future.

Authors:  Catalin S Buhimschi; Vineet Bhandari; Yiping W Han; Antonette T Dulay; Margaret A Baumbusch; Joseph A Madri; Irina A Buhimschi
Journal:  Curr Opin Infect Dis       Date:  2009-06       Impact factor: 4.915

7.  Uncultivated bacteria as etiologic agents of intra-amniotic inflammation leading to preterm birth.

Authors:  Yiping W Han; Tao Shen; Peter Chung; Irina A Buhimschi; Catalin S Buhimschi
Journal:  J Clin Microbiol       Date:  2008-10-29       Impact factor: 5.948

Review 8.  Antimicrobials for preterm birth prevention: an overview.

Authors:  Akila Subramaniam; Adi Abramovici; William W Andrews; Alan T Tita
Journal:  Infect Dis Obstet Gynecol       Date:  2012-02-25

9.  Outcome of vaginal progesterone as a tocolytic agent: randomized clinical trial.

Authors:  Soraya Saleh Gargari; Malihe Habibolahi; Zahra Zonobi; Zahra Khani; Fatemeh Sadat Sarfjoo; Atefeh Kazemi Robati; Roja Etemad; Zohreh Karimi
Journal:  ISRN Obstet Gynecol       Date:  2012-05-23

10.  Reference population for international comparisons and time trend surveillance of preterm delivery proportions in three countries.

Authors:  Nils-Halvdan Morken; Ida Vogel; Karin Kallen; Rolv Skjaerven; Jens Langhoff-Roos; Ulrik Schiøler Kesmodel; Bo Jacobsson
Journal:  BMC Womens Health       Date:  2008-09-25       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.